K.G. Jebsen Brain Tumor Centre

The centre’s primary goal is to come up with a better and more predictable treatment for patients with malignant brain tumours.

The establishment of this interdisciplinary centre was made possible through grants from the Kristian Gerhard Jebsen Foundation and from the Faculty of Medicine and Dentistry, University of Bergen and Haukeland University Hospital. In addition, the researchers at the centre receive support from the Norwegian Cancer Society, the  Research Council of Norway  and the Bergen Research Foundation, as well as the European Commission.

The K.G. Jebsen BTRC and the University of Bergen-NorLux partnership fosters excellence in brain tumour research, amalgamating the expertise of scientists, clinical investigators and physicians in a virtual laboratory environment at the University of Bergen, The Haukeland University Hospital and Luxembourg Institute of Health (L.I.H.), Luxembourg. A stimulating research environment has been created allowing scientists to share ideas, resources and equipment in an atmosphere conductive to achieving excellence in molecular neuro-oncology research, scientific output and clinical research.

Mission
The primary goal of the Kristian Gerhard Jebsen Brain Tumour Research Centre is to provide better and more predictable treatment of patients with malignant brain tumors. This will be done by translating new important knowledge gained from our  extensive research activities into clinical trials where scientists and health care clinicians work in partnership to translate laboratory findings into new or improved forms of therapy. 

Focus
We focus on primary brain tumours as well as metastatic tumours to the brain. Our research activities within the NorLux laboratories focus on basic and translational research,  where the aim is to understand better how brain tumors are initiated and to better delineate the mechanisms responsible for tumor growth. The K.G. Jebsen BTRC focuses on bringing this knowledge into the clinic.

Board of Directors:

Professor Rolf Bjerkvig
Director of the K.G. Jebsen BTRC Head of Oncology Department, Institute of Health (L.I.H.), Luxembourg.

Professor Morten Lund-Johansen
Chief medical supervisor, Section of tumor surgery. Department of Neurosurgery, Haukeland University Hospital.

Professor Olav Mella
Chairman Department of Oncology, Haukeland University Hospital.

The centre in brief:

Leader: Rolf Bjerkvig
Start up: 2014
Host institution: University of Bergen
Funding: 16 MNOK
Home page: K.G. Jebsen Brain Tumor Research Centre

Contact information

K.G. Jebsen Brain Tumour Research Centre
University of Bergen
Department of Biomedicine
Jonas Liesvei 91
5009 Bergen
Norway

Advisory Board:

Professor, Dr. med. Michael Weller
Laboratory of Molecular Oncology Department of Neurology University Hospital Zurich, Switzerland.

Professor James Rutka,  M.D, Ph.D, FRCSC
Chair, Division of Surgery Co-director,  The Arthur and Sonia Labatt Brain Tumour Research Centre University of Toronto, Canada.

Professor dr. Manfred Westphal
Department of Neurosurgery University Cancer Center, Hamburg, Germany Neuro-Oncology Program Hospital.

Media

Bergens Tidende, 3.7.2015:
Jeg har ikke sett liknende i mine 20 år som forsker

Det norske kongehus 08.05.2015
Kong Harald overrakte Kong Olav Vs Kreftforskningspris til senterleder Rolf Bjerkvig. Kreftforeningen intervjuer Rolf Bjerkvig i anledning utdeling av Kong Olav Vs Kreftforksningspris

Dagens medisin, 18.6.2015:
Ny bruk av gammelt antipsykotika?

Bergens Tidende, 3.6.2015:
Kreft er like komplisert som livet

På Høyden, 16.6.2014:
Vil oversette kreftkunnskap til behandling

Dagens medisin, 13.6.2014:
Åpner forskningssenter for hjernekreft

Bergens Tidende, 11.12.2013:
Bergensforsker får 16 millioner

News from Stiftelsen Kristian Gerhard Jebsen